RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern
M. Le Gars (Leiden, Netherlands), J. Sadoff (Leiden, Netherlands), G. Shukarev (Leiden, Netherlands), D. Heerwegh (Beerse, Belgium), C. Truyers (Beerse, Belgium), G. Scheper (Leiden, Netherlands), J. Hendriks (Leiden, Netherlands), M. Mcelrath (Seattle, WA, United States of America), S. De Rosa (Seattle, WA, United States of America), K. Cohen (Seattle, WA, United States of America), M. Douoguih (Leiden, Netherlands), F. Struyf (Beerse, Belgium), H. Schuitemaker (Leiden, Netherlands)
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Le Gars (Leiden, Netherlands), J. Sadoff (Leiden, Netherlands), G. Shukarev (Leiden, Netherlands), D. Heerwegh (Beerse, Belgium), C. Truyers (Beerse, Belgium), G. Scheper (Leiden, Netherlands), J. Hendriks (Leiden, Netherlands), M. Mcelrath (Seattle, WA, United States of America), S. De Rosa (Seattle, WA, United States of America), K. Cohen (Seattle, WA, United States of America), M. Douoguih (Leiden, Netherlands), F. Struyf (Beerse, Belgium), H. Schuitemaker (Leiden, Netherlands). RCT Abstract - Ad26.COV2.S induces SARS-CoV-2 spike protein-specific cellular immunity and humoral immune responses that cover variants of concern. 490
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: